pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
istradefylline
Nourianz (istradefylline)
Parkinson's Disease
Kyowa Hakko USA Inc
0
catalysts
Phase 2
isuzinaxib
isuzinaxib [INN]
Acute Renal Failure (ARF) (Acute Kidney Injury)
AptaBio Therapeutics Inc
0
catalysts
Phase 2
it-hMSC
Ageing
Stemedica Cell Technologies Inc
0
catalysts
Phase 2
← prev
page 188 of 231
next →
131
Pain
89
Neurology
1
itanapraced
itanapraced [INN]
Mild Cognitive Impairment
CereSpir Inc
0
catalysts
Phase 3
itepekimab
Chronic Obstructive Pulmonary Disease (COPD)
Interleukin-33
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Marketed
itraconazole
Tolsura (itraconazole)
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndr…
Lanosterol 14-alpha demethylase
$INTI
Inhibitor Therapeutics, Inc.
0
catalysts
Phase 2
itruvone
Major Depressive Disorder
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Marketed
ivabradine hydrochloride
Ivabradine Hydrochloride (ivabradine hydrochloride)
Congestive Heart Failure (Heart Failure)
Ingenus Pharmaceuticals LLC
0
catalysts
Phase 2
ivaltinostat
ivaltinostat [INN]
Pancreatic Ductal Adenocarcinoma
CG Invites Co Ltd
0
catalysts
Phase 3
ivarmacitinib sulfate
Ulcerative Colitis
Reistone Biopharma Co Ltd
0
catalysts
pre_registration
ivonescimab
Non-Small Cell Lung Cancer
$SMMT
Summit Therapeutics Inc.
0
catalysts
Marketed
ivosidenib
Tibsovo (ivosidenib)
Chondrosarcoma
Isocitrate dehydrogenase [NADP] cytoplasmic
Les Laboratoires Servier SAS
0
catalysts
Phase 3
ivospemin hydrochloride
Pancreatic Ductal Adenocarcinoma
Panbela Therapeutics Inc
0
catalysts
Marketed
ixabepilone
Ixempra (ixabepilone)
Metastatic Breast Cancer
R-Pharm US LLC
0
catalysts
Marketed
ixazomib citrate
Ninlaro (ixazomib citrate)
Refractory Multiple Myeloma
26S proteasome
Millennium Pharmaceuticals Inc
0
catalysts
Marketed
ixekizumab
Taltz (ixekizumab)
Plaque Psoriasis (Psoriasis Vulgaris)
Eli Lilly and Co
0
catalysts
Phase 3
ixoberogene soroparvovec
Wet (Neovascular / Exudative) Macular Degeneration
Adverum Biotechnologies Inc
0
catalysts
Phase 3
izalontamab brengitecan
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 1
izastobart
izastobart [INN]
Solid Tumor
$BIIB
BIOGEN INC.
0
catalysts
Marketed
japanese encephalitis [strain SA14-14-2] vaccine
Ixiaro
Japanese Encephalitis
Valneva USA Inc
0
catalysts
Marketed
ketoprofen ER
Ketoprofen (ketoprofen)
Osteoarthritis Pain
Mylan Pharmaceuticals Inc
0
catalysts
Marketed
ketotifen fumarate
Ketotifen Fumarate (ketotifen fumarate)
Allergic Conjunctivitis
Sentiss Pharmaceuticals LLC
0
catalysts
Preclinical
kynurenic acid
Idiopathic Pulmonary Fibrosis
BirchBioMed Inc
0
catalysts
Marketed
labetalol
Labetalol (labetalol [INN])
Hypertension
Macleods Pharma USA Inc
0
catalysts
Phase 1
labuxtinib
labuxtinib [INN]
Chronic Urticaria
Third Harmonic Bio Inc
0
catalysts
Preclinical
lactic acid SR
lactic acid [USP]
Bacterial Vaginosis
Mucommune LLC
0
catalysts
Marketed
lactitol
Pizensy (lactitol [INN])
Constipation
Sebela Pharmaceuticals Inc
0
catalysts
Marketed
lactulose
Kristalose (lactulose)
Constipation
$CPIX
CUMBERLAND PHARMACEUTICALS INC
0
catalysts
Phase 2
lacutamab
lacutamab [INN]
Anaplastic Large Cell Lymphoma (ALCL)
$IPHA
Innate Pharma SA
0
catalysts
Phase 1
lacutoclax
lacutoclax [INN]
Chronic Myelomonocytic Leukemia (CMML)
Newave Pharmaceutical Co Ltd
0
catalysts
